Evotec expands CRISPR-based technology offering with licence from ERS genomics

Hamburg, Germany, 02 May 2018: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that it has expanded its CRISPR service offering with the addition of a licence from ERS Genomics Limited. With this licence, Evotec gains access to the leading technology for gene ...

Topics: Corporate, genomics, technology, crispr Read More

Most Read

Posts by Topic